LDHA and triple-negative breast carcinoma: For example, disulfiram, a broad ALDH inhibitor, was shown to eradicate paclitaxel-resistant triple negative breast cancer cells [24] as well as kinase inhibitor-tolerant lung cancer cells addicted to specific mutant oncogene drivers [30].